A groundbreaking study published in Molecular Cancer Therapeutics brings new hope to the fight against pediatric cancer. Led by the Children’s Cancer Institute, in collaboration with UNSW Sydney, Monash University, and Queensland Children’s Hospital, researchers have discovered that a specific class of targeted cancer drugs could benefit a much broader group of children than previously recognised.

Dr Ross Walker speaks with Associate Professor Emmy Fleuren - Team Leader at Children's Cancer Institute